BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

158 related articles for article (PubMed ID: 1409016)

  • 1. Effect of vasopressin administration and deficiency upon 3H-AVP binding sites in the CNS and periphery during development.
    Szot P; Myers KM; Dorsa DM
    Peptides; 1992; 13(2):389-94. PubMed ID: 1409016
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Enhanced phosphoinositol hydrolysis in response to vasopressin in the septum of the homozygous Brattleboro rat.
    Shewey LM; Brot MD; Szot P; Dorsa DM
    Brain Res; 1989 Jan; 478(1):95-102. PubMed ID: 2924125
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Enhanced binding of 3H-arginine8-vasopressin in the Brattleboro rat.
    Shewey LM; Dorsa DM
    Peptides; 1986; 7(4):701-4. PubMed ID: 3763443
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [3H]AVP binding to rat renal tubular receptors during long-term treatment with an antagonist of arginine vasopressin.
    Mah SC; Whitebread SE; De Gasparo M; Hofbauer KG
    Peptides; 1988; 9(3):595-600. PubMed ID: 3420014
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Regulation of vasopressin receptors and phosphoinositide hydrolysis in the septum of heterozygous and homozygous Brattleboro rats.
    Shewey LM; Boer GJ; Szot P; Dorsa DM
    Neuroendocrinology; 1989 Sep; 50(3):292-8. PubMed ID: 2552343
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Characterization of a specific, high affinity [3H]arginine8 vasopressin-binding site on liver microsomes from different strains of rat and the role of magnesium.
    Gopalakrishnan V; Triggle CR; Sulakhe PV; McNeill JR
    Endocrinology; 1986 Mar; 118(3):990-7. PubMed ID: 3004905
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Arginine vasopressin as an intragonadal hormone in Brattleboro rats: presence of a testicular vasopressin-like peptide and functional vasopressin receptors.
    Kasson BG; Hsueh AJ
    Endocrinology; 1986 Jan; 118(1):23-31. PubMed ID: 3000735
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Physiologic regulation and distribution of the renal vasopressin receptor.
    Finkel MS; Mendelsohn FA; Quirion R; Zamir N; Keiser HR
    Pharmacology; 1989; 39(3):165-75. PubMed ID: 2531425
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Characterization of a 3H-arginine8-vasopressin binding site in the cingulate gyrus of the rat pup.
    Szot P; Myers KM; Swank M; Dorsa DM
    Peptides; 1989; 10(6):1231-7. PubMed ID: 2622802
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Vasopressin responses and receptors in the mesenteric vasculature of estrogen-treated rats.
    St-Louis J; Parent A; Larivière R; Schiffrin EL
    Am J Physiol; 1986 Nov; 251(5 Pt 2):H885-9. PubMed ID: 3777197
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pituitary binding of vasopressin is altered by experimental manipulations of the hypothalamo-pituitary-adrenocortical axis in normal as well as homozygous (di/di) Brattleboro rats.
    Antoni FA; Holmes MC; Kiss JZ
    Endocrinology; 1985 Oct; 117(4):1293-9. PubMed ID: 3161722
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Guanine nucleotide regulation of [3H]vasopressin binding to liver plasma membranes and solubilized receptors. Evidence for the involvement of a guanine nucleotide regulatory protein.
    Bojanic D; Fain JN
    Biochem J; 1986 Dec; 240(2):361-5. PubMed ID: 2949738
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Identification and characterization of arginine vasopressin receptors in the rat testis.
    Meidan R; Hsueh AJ
    Endocrinology; 1985 Jan; 116(1):416-23. PubMed ID: 2981073
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hepatic vasopressin receptor: differential effects of divalent cations, guanine nucleotides, and N-ethylmaleimide on agonist and antagonist interactions with the V1 subtype receptor.
    Gopalakrishnan V; McNeill JR; Sulakhe PV; Triggle CR
    Endocrinology; 1988 Aug; 123(2):922-31. PubMed ID: 2969327
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Ontogeny of vasopressin and oxytocin binding sites in the brain of Wistar and Brattleboro rats as demonstrated by lightmicroscopical autoradiography.
    Snijdewint FG; Van Leeuwen FW; Boer GJ
    J Chem Neuroanat; 1989; 2(1):3-17. PubMed ID: 2551339
    [TBL] [Abstract][Full Text] [Related]  

  • 16. V1-type vasopressin receptors in rat brain septum: binding characteristics and effects on inositol phospholipid metabolism.
    Shewey LM; Dorsa DM
    J Neurosci; 1988 May; 8(5):1671-7. PubMed ID: 2835449
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Direct identification of the rat hepatocyte arginine8 vasopressin receptor with a radiolabelled V1-selective antagonist.
    Cornett LE; Cate CM
    J Recept Res; 1989; 9(1):1-18. PubMed ID: 2915345
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Neonatal exposure to vasopressin decreases vasopressin binding sites in the adult kidney.
    Handelmann GE; Sayson SC
    Peptides; 1984; 5(6):1217-9. PubMed ID: 6099566
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prenatal development of the Brattleboro rat is influenced by genotype and lysine vasopressin treatment of the mother.
    Snijdewint FG; Boer GJ; Swaab DF
    Biol Neonate; 1988; 53(5):295-304. PubMed ID: 3390492
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Regulation of (3H) arginine8 vasopressin binding to the rat renal medulla by guanine nucleotides.
    Cornett LE; Dorsa DM
    J Recept Res; 1986; 6(2):127-40. PubMed ID: 3522888
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.